Startseite Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays

  • Qiujin Shen , Johan Björkesten , Joakim Galli , Daniel Ekman , John Broberg , Niklas Nordberg , Annika Tillander , Masood Kamali-Moghaddam EMAIL logo , Gunnel Tybring und Ulf Landegren EMAIL logo
Veröffentlicht/Copyright: 17. Oktober 2017
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background

A number of factors regarding blood collection, handling and storage may affect sample quality. The purpose of this study was to assess the impact on plasma protein profiles by delayed centrifugation and plasma separation and multiple freeze-thaw cycles.

Methods

Blood samples drawn from 16 healthy individuals were collected into ethylenediaminetetraacetic acid tubes and kept either at 4 °C or 22 °C for 1–36 h prior to centrifugation. Plasma samples prepared 1 h after venipuncture were also subjected to two to eight cycles of freezing at −80 °C and thawing at 22 °C. Multiplex proximity extension assay, an antibody-based protein assay, was used to investigate the influence on plasma proteins.

Results

Up to 36 h delay before blood centrifugation resulted in significant increases of 16 and 40 out of 139 detectable proteins in samples kept at 4 °C or 22 °C, respectively. Some increases became noticeable after 8 h delay at 4 °C but already after 1 h at 22 °C. For samples stored at 4 °C, epidermal growth factor (EGF), NF-kappa-B essential modulator, SRC, interleukin 16 and CD6 increased the most, whereas the five most significantly increased proteins after storage at 22 °C were CD40 antigen ligand (CD40-L), EGF, platelet-derived growth factor subunit B, C-X-C motif chemokine ligand 5 and matrix metallopeptidase 1 (MMP1). Only matrix metallopeptidase 7 (MMP7) decreased significantly over time and only after storage at 22 °C. No protein levels were found to be significantly affected by up to eight freeze-thaw cycles.

Conclusions

Plasma should be prepared from blood after a limited precentrifugation delay at a refrigerated temperature. By contrast, the influence by several freeze-thaw cycles on detectable protein levels in plasma was negligible.


Corresponding authors: Associate Prof. Masood Kamali-Moghaddam, PhD, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala Biomedical Center, Husargatan 3, Uppsala, Sweden, Phone: +46 18 4714454, Fax: +46 18 4714808; and Prof. Ulf Landegren, PhD, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala Biomedical Center, Husargatan 3, Uppsala, Sweden, Phone: +46 18 4714910, Fax: +46 18 4714808

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Swedish Research Council VR: no. 829-2009-6285 (BBMRI.se); European Research Council under the European Union’s Seventh Framework Programme (FP/2007–2013): no. 313010 (BBMRI-LPC), no. 294409 (ProteinSeq); Marie Curie ITN (FP7/2007–2013): no. 316929 (GastricGlycoExplorer).

  3. Employment or leadership: DE is an employer of Olink Bioscience; JB and NN are employers of Olink Proteomics.

  4. Honorarium: None declared.

  5. Competing interests: UL is a founder and shareholder of Olink Proteomics and Olink Bioscience, having rights to the proximity ligation and extension technology. The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. van Ommen G-J, Törnwall O, Bréchot C, Dagher G, Galli J, Hveem K, et al. BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres. Eur J Hum Genet 2015;23:893–900.10.1038/ejhg.2014.235Suche in Google Scholar PubMed PubMed Central

2. Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, et al. Standard preanalytical coding for biospecimens; defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev 2010;19:1004–11.10.1158/1055-9965.EPI-09-1268Suche in Google Scholar PubMed

3. Lehmann S, Guadagni F, Moore H, Ashton G, Barnes M, Benson E, et al. Standard preanalytical coding for biospecimens: review and implementation of the sample PREanalytical Code (SPREC). Biopreserv Biobank 2012;10:366–74.10.1089/bio.2012.0012Suche in Google Scholar PubMed PubMed Central

4. Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, et al. Standard operating procedures for serum and plasma collection. J Proteome Res 2010;8:113–7.10.1021/pr800545qSuche in Google Scholar PubMed PubMed Central

5. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262–77.10.1002/9783527609482.ch3Suche in Google Scholar

6. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845–67.10.1074/mcp.A300001-MCP200Suche in Google Scholar

7. Assarsson E, Lundberg M, Holmquist G, Björkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 2014;9:e95192.10.1371/journal.pone.0095192Suche in Google Scholar PubMed PubMed Central

8. Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res 2011;39:e102.10.1093/nar/gkr424Suche in Google Scholar PubMed PubMed Central

9. Larssen P, Wik L, Czarnewski P, Eldh M, Lof L, Goran Ronquist K, et al. Tracing cellular origin of human exosomes using multiplex proximity extension assays. Mol Cell Proteomics 2017;16:1–30.10.1074/mcp.M116.064725Suche in Google Scholar PubMed PubMed Central

10. Björkesten J, Enroth S, Shen Q, Wik L, Hougaard D, Cohen A, et al. Stability of proteins in dried blood spot biobanks. Mol Cell Proteomics 2017;16:1286–96.10.1074/mcp.RA117.000015Suche in Google Scholar PubMed PubMed Central

11. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med 2007;45:565–76.10.1515/CCLM.2007.110Suche in Google Scholar

12. Hsieh SY, Chen RK, Pan YH, Lee HL. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 2006;6:3189–98.10.1002/pmic.200500535Suche in Google Scholar

13. Ellervik C, Vaught J. Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem 2015;61:914–34.10.1373/clinchem.2014.228783Suche in Google Scholar

14. Holland NT, Smith MT, Eskenazi B, Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003;543:217–34.10.1016/S1383-5742(02)00090-XSuche in Google Scholar

15. Newhall KJ, Diemer GS, Leshinsky N, Kerkof K, Chute HT, Russell CB, et al. Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots. Clin Chem 2010;56:1483–91.10.1373/clinchem.2006.144618Suche in Google Scholar

16. Aziz N, Irwin MR, Dickerson SS, Butch AW. Spurious tumor necrosis factor-alpha and interleukin-6 production by human monocytes from blood collected in endotoxin-contaminated vacutainer blood collection tubes. Clin Chem 2004;50:2215–6.10.1373/clinchem.2004.040162Suche in Google Scholar

17. Yokota M, Tatsumi N, Nathalang O, Yamada T, Tsuda I. Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal 1999;13:133–40.10.1002/(SICI)1098-2825(1999)13:3<133::AID-JCLA8>3.0.CO;2-0Suche in Google Scholar

18. Lengellé J, Panopoulos E, Betsou F. Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 2008;44:275–82.10.1016/j.cyto.2008.08.010Suche in Google Scholar

19. Betsou F, Gunter E, Clements J, De Souza Y, Goddard KA, Guadagni F, et al. Identification of evidence-based biospecimen quality-control tools: a report of the international society for biological and environmental repositories (ISBER) biospecimen science working group. J Mol Diagnostics 2013;15:3–16.10.1016/j.jmoldx.2012.06.008Suche in Google Scholar

20. Lee J-E, Kim J-W, Han B-G, Shin S-Y. Impact of whole-blood processing conditions on plasma and serum concentrations of cytokines. Biopreserv Biobank 2016;14:51–5.10.1089/bio.2015.0059Suche in Google Scholar

21. De Jongh R, Vranken J, Vundelinckx G, Bosmans E, Maes M, Heylen R. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine 1997;9:696–701.10.1006/cyto.1997.0217Suche in Google Scholar PubMed

22. Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464–9.10.1016/j.clinbiochem.2012.01.012Suche in Google Scholar PubMed

23. Tanner M, Kent N, Smith B, Fletcher S, Lewer M. Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation. Ann Clin Biochem 2008;45:375–9.10.1258/acb.2007.007183Suche in Google Scholar PubMed

24. Chaigneau C, Cabioch T, Beaumont K, Betsou F. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation. Clin Chem Lab Med 2007;45:1390–5.10.1515/CCLM.2007.160Suche in Google Scholar PubMed

25. Lee JE, Kim SY, Shin SY. Effect of repeated freezing and thawing on biomarker stability in plasma and serum samples. Osong Public Health Res Perspect 2015;6:357–62.10.1016/j.phrp.2015.11.005Suche in Google Scholar PubMed PubMed Central

26. Mitchell BL, Yasui Y, Li CI, Fitzpatrick AL, Lampe PD. Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects. Cancer Inform 2005;1:98–104.10.1177/117693510500100110Suche in Google Scholar

27. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009;10:52.10.1186/1471-2172-10-52Suche in Google Scholar PubMed PubMed Central


Supplemental Material:

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2017-0648).


Received: 2017-7-24
Accepted: 2017-9-11
Published Online: 2017-10-17
Published in Print: 2018-3-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Visual assessment of sample quality: quo usque tandem?
  4. Reviews
  5. Machine learning in laboratory medicine: waiting for the flood?
  6. Is irisin the new player in exercise-induced adaptations or not? A 2017 update
  7. Opinion Paper
  8. Can a combination of average of normals and “real time” External Quality Assurance replace Internal Quality Control?
  9. Genetics and Molecular Diagnostics
  10. The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography
  11. General Clinical Chemistry and Laboratory Medicine
  12. Laboratory performance of sweat conductivity for the screening of cystic fibrosis
  13. Making sense of a haemolysis monitoring and reporting system: a nationwide longitudinal multimethod study of 68 Australian laboratory participant organisations
  14. Visual assessment of hemolysis affects patient safety
  15. Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays
  16. Validation of the Six Sigma Z-score for the quality assessment of clinical laboratory timeliness
  17. Proficiency testing program for hemoglobin E, A2 and F analysis in Thailand using lyophilized hemoglobin control materials
  18. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm
  19. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
  20. An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer
  21. Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples
  22. Reference Values and Biological Variations
  23. Reference intervals for stone risk factors in 24-h urine among healthy adults of the Han population in China
  24. Cardiovascular Diseases
  25. Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of Cardiology
  26. Infectious Diseases
  27. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome
  28. Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbation
  29. Corrigendum
  30. Corrigendum to: Validation of a pneumatic tube system to transport surgical pathology biopsy samples
  31. Letters to the Editor
  32. A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium
  33. Detection and a functional characterization of the novel FBN1 intronic mutation underlying Marfan syndrome: case presentation
  34. Effect of haemolysis on the determination of CCL17/thymus and activation-regulated chemokine (TARC) and CCL22/macrophage-derived chemokine (MDC)
  35. Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry
  36. Impact of citrated blood collection tubes on red cell morphology: implications for the measurement of plasma glucose
  37. Validation of a pneumatic tube system to transport surgical pathology biopsy samples
  38. Antioxidant capacity in patients with type 2 diabetes: a preliminary investigation on gender-specific differences in an Italian population
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-0648/html
Button zum nach oben scrollen